microbiota studies, Cdiff, AMR and fungal infections.
Joined January 2018
- Tweets 892
- Following 953
- Followers 916
- Likes 1,940
145 Photos and videos
Ed Kuijper retweeted
Bundibugyo ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the ESCMID Emerging Infections Subcommittee
@CMIJournal @ESCMID clinicalmicrobiologyandinfec…
25
47
4,105
Ed Kuijper retweeted
May 19
Not just passengers: Phages as agents of genetic exchange in fecal microbiota transplantation sciencedirect.com/science/ar…
1
1
2
234
May 13
Andes hantavirus outbreak on a cruise ship - an ESCMID Emerging Infections Subcommittee (EIS) rapid assessment - Clinical Microbiology and Infection clinicalmicrobiologyandinfec…
1
1
71
Ed Kuijper retweeted
May 11
New bookchapter published! The book Clostridioides difficile has a chapter on Nanoluciferase use by Jeroen Corver, Ana Paiva and myself: link.springer.com/book/10.10… Also check out the contributions of all the other experts in this volume!
2
2
270
Ed Kuijper retweeted
Mar 10
Paper 🚨: in this Narrative Review we describe the challenges and opportunity of a microbiome research facility, based on our experiences at @LUMC_Leiden with Center for Microbiome Analyses and Therapeutics (CMAT) #ESGHAMI @ESCMID @CMIJournal @EdKuijper2 sciencedirect.com/science/ar…
5
4
957
Ed Kuijper retweeted
🚨Publication alert! In this manuscript we describe the characterization of the non-toxigenic C. difficile (#NTCD) strain L-NTCD03 that we have used in our controlled human colonization experiments. academic.oup.com/femsmicrobe…
1
1
1
163
Ed Kuijper retweeted
📢Publication alert: Clinical prevalence of collateral sensitivity: a systematic exploration of multicentre antimicrobial surveillance data 💊wonderful work from Coen van Hasselt's lab, with a minor contribution from yours truly - sciencedirect.com/science/ar…
1
1
192
Feb 21
clinicalmicrobiologyandinfec…
Review of our experiences in the past 6 years to establish a Microbiota Center in an academic setting with many stakeholders and an excellent research group of George Zeller. @SmitsLab @NicolasBenech2 @CMIJournal @EurFmt
3
4
586
Jan 14
Amazing data on the Cfr -mediated antibiotic resistance in Cdiff. Typical a One Heath resistance mechanism? Also found in LA-MRSA and VRE...
Jan 13
Epidemiology suggests that cfr(B) is associated with PhLOPSa resistance in C. difficile, but is this causative? Yes it is. We show this in our most recent preprint: biorxiv.org/content/10.64898…
71
Ed Kuijper retweeted
27 Dec 2025
Clostridioides difficile is a gram-positive spore-forming anaerobic bacterium that can produce toxins.
Learn more about the epidemiology, diagnosis, and treatment of recurrent C difficile infections in this JAMA Insights: ja.ma/3N2AKdz
ALT A flowchart titled, 'Diagnosis of Recurrent Clostridioides difficile Infection'. It shows steps for diagnosis from suspected infection to treatment options. Text includes, 'Sensitive screening assay', 'Specific test', and treatment options like 'Fecal microbiota transplant'.
3
98
265
25,444
Ed Kuijper retweeted
22 Dec 2025
As 2025 comes to an end, it is time to reflect on an exceptionally productive scientific year (22 manuscripts so far). I am grateful for these interactions, proud of the work, and looking forward to more exciting science with my team in 2026! sites.google.com/view/expbac…
1
2
159
Ed Kuijper retweeted
26 Nov 2025
Donor screening for #FMT gets ever more complicated, but is there rationale for this? Great to play a part in this critical appraisal and international Delphi process on this issue, now out in @Gut_BMJ: gut.bmj.com/content/early/20… @EdKuijper2 @IHepatology @ImperialMDR @EurFmt
8
8
1,421
9 Nov 2025
Excellent news from Gut....our article "Towards Optimising and Standardising Donor Screening for Faecal Microbiota Transplantation" has been accepted. International collaboration with FMT experts, completed with a Delphi-survey. More news in the following weeks.
1
1
87
8 Nov 2025
6 Nov 2025
🚨Publication alert! Stoked to report the structural basis for activity of a novel class of antimicrobials targeting Gram positive priority pathogens in @NatureComms. There is something for everyone on this paper; highlights 👇 1/9 doi.org/10.1038/s41467-025-6…
1
64
26 Oct 2025
Practical information for genereal physicians;
Recurrent Clostridioides difficile Infections jamanetwork.com/journals/jam…
@SmitsLab @CdiffSupport @jvanprehn @marcellakrutova
3
4
209
13 Oct 2025
Nat Com 2025: rdcu.be/eKOLx
New glycopeptide EVG7 with excellent activity against C. difficile in mouse model. Excellent collaboration of Leiden with College of Veterinary Medicine, NC State University, US.
2
97
Ed Kuijper retweeted
15 Jul 2025
Join us !
Open #Postdoc position in my lab (Paris, France), to work on the Role of the Gut #microbiota in Host Cells Energy Metabolism in Health and #IBD
see details here
🔽🔽🔽🔽
euraxess.ec.europa.eu/jobs/3…
please RT
1
29
50
4,843
30 Jun 2025
An important call is emerging from scientists, physicians, and patients to add C. difficile to the WHO priority list.....@ECDC_EU @rivm @NVMM_NL @EurFmt
thelancet.com/pdfs/journals/…
1
4
161
5 Jun 2025
Finally completed, with our Serbian collegues!
Emerging Clostridioides difficile strains belonging to PCR ribotype 955 in Serbia are distinct from metronidazole resistant RT955 outbreak isolates from the UK medrxiv.org/content/10.1101/…
2
8
343
21 May 2025
21 May 2025
Ons hele gezin (Adam) probeert sinds 10.00 uur tickets te krijgen voor het Adam ringfeest; we kwamen een paar maal uit de wachtruimte en bestelde de tickets, maar werden voor de bevestiging uit de site gegooid. Wat een amateurisme en onvermogen... # amsterdam ring tickets
422